Additionally, leveraging this network information, a strategic drug repurposing approach was made by exploring existing drugs on the market or in clinical trials targeting AD and DM against LPARs, SPIKE, and LPAR-SPIKE complex to discern potential therapeutic candidates with the capacity to modulate the protein complexes. This evidence concerns the gene CHMP5 and Alzheimer disease.